Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Evonik Industries AG is a leading global specialty chemicals company headquartered in Essen, Germany. Founded in 2007 from the restructuring of RAG AG, it focuses exclusively on specialty chemicals after divesting its energy and real estate businesses, generating around 80% of sales from market-leading positions in this core area. The company organizes operations into key segments including Specialty Additives for coatings and consumer goods, Nutrition & Care for personal care, pharmaceuticals, animal nutrition, and drug delivery, Smart Materials for resource-efficient innovations, and Performance Materials for high-volume intermediates in mobility, plastics, and superabsorbents. With approximately 32,000 employees across more than 100 countries and production sites in about 25 nations, Evonik serves diverse industries such as tires, detergents, wind turbines, medical devices, and livestock farming. In 2024, it reported sales of €15.2 billion and adjusted EBITDA of €2.1 billion, underscoring its role as a key innovator enhancing product performance and sustainability worldwide.
Operating margin is thin at 4.56%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue declined 7.2% YoY. The question is whether this is cyclical or a structural shift.
Free cash flow declined 20% versus the prior year, cash generation momentum has weakened. Net debt of €3.25B represents 4.7x FCF, leverage limits flexibility.
Profitability & Returns
Revenue (TTM)
€13.72B
▼ -7.2% YoY
Net Income (TTM)
€170M
▲ +15.4% YoY
Op. Margin
4.17%
▲ +0.3pp YoY
ROIC
3.38%
▲ +0.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€683M
▼ -20.4% YoY
Op. Cash Flow (TTM)
€770M
▼ -10.4% YoY
Net Debt
€3.25B
Cash & Equiv.
€623M
3Y CAGR: -8.7%
3Y CAGR: -4.0%
Continue Research